AVNS (Avanos Medical) Short-Term Debt: $10.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AVNS Avanos Medical Inc AVNS
62 GF Score
Price $24.96
GF Value $19.38
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Avanos Medical Short-Term Debt?

Avanos Medical AVNS -0.04% 62 Short-Term Debt is $10.9 Mil as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.38 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Avanos Medical's Short-Term Debt for the quarter that ended in Mar. 2026 was $10.9 Mil.

Avanos Medical's quarterly Short-Term Debt increased from Sep. 2025 ($9.4 Mil) to Dec. 2025 ($10.2 Mil) and increased from Dec. 2025 ($10.2 Mil) to Mar. 2026 ($10.9 Mil).

Avanos Medical's annual Short-Term Debt increased from Dec. 2023 ($8.6 Mil) to Dec. 2024 ($9.4 Mil) and increased from Dec. 2024 ($9.4 Mil) to Dec. 2025 ($10.2 Mil).

Avanos Medical Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Avanos Medical Short-Term Debt Related Terms

Avanos Medical Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Avanos Medical's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avanos Medical Short-Term Debt Chart

Avanos Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 6.20 8.60 9.40 10.20

Avanos Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.40 9.40 9.40 10.20 10.90
AVNS
62GF Score
Avanos Medical Inc AVNS
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $10.9 Mil mean?
Avanos Medical (AVNS) has a Short-Term Debt of $10.9 Mil as of Mar. 2026.
Is Avanos Medical's Short-Term Debt too high?
Avanos Medical's current Short-Term Debt is $10.9 Mil. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Short-Term Debt compare to LMRI and AORT?
Avanos Medical's Short-Term Debt of $10.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Avanos Medical's current Short-Term Debt is $10.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.38, compared to a current price of $24.96 — trading 28.8% above its estimated fair value. The current Short-Term Debt is $10.9 Mil. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Short-Term Debt is $10.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avanos Medical (AVNS) Overvalued in 2026?

Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued. The current stock price of $24.96 is trading 28.8% above its estimated GF Value™ of $19.38. GuruFocus considers Avanos Medical to be Modestly Overvalued.

Key valuation signals for AVNS:

  • Short-Term Debt: $10.9 Mil
  • GF Value™: $19.38 vs. price of $24.96 (28.8% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avanos Medical Business Description

Address 5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score

Get the complete analysis for AVNS

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.96
Price
$19.38
GF Value